Introduction
============

Vascular remodeling is one of the most important mechanisms responsible for lumen narrowing in many cardiovascular pathologies ([@B21]). Inward arterial remodeling is associated with high cardiovascular mortality, while outward vascular remodeling is considered to be a positive compensatory mechanism that provides adequate blood flow ([@B28]). We have demonstrated previously that tissue-type plasminogen activator (tPA) attenuated inward arterial remodeling ([@B22]).

Despite the active interest of many research groups to the problem of regulation of arterial remodeling, highly effective mechanisms are still to be found ([@B10]). The mechanisms, underlying tPA effects in the vessel wall, stay unclear.

Vascular remodeling involve many processes including cell proliferation, migration, extracellular matrix remodeling, and changes in vascular tone ([@B2]; [@B28]). There are contradictory data about the influence of tPA; it contributes to cell proliferation, but also in the previous study, tPA reduced neointima formation ([@B22]).

To clarify mechanisms that may lead to the positive outward remodeling induced by tPA, we hypothesized that tPA might affect the expression of genes, which might regulate the remodeling response of the injured artery. To assess the role of gene expression changes in early processes leading to the outward vascular remodeling induced by tPA, we investigated alterations in gene expression profiles of rat common carotids after injury and local treatment with the recombinant tPA.

Materials and Methods
=====================

Ethics Statement
----------------

Animal studies were conducted in accordance with the principles of the Basel Declaration, approved guidelines of the Institutional Animal Care and Use Committee of the National Medical Research Center of Cardiology (Permit No. 385.06.2009) and the Guide for the Care and Use of Laboratory Animals (8th Edition, 2011, The National Academies Press, United States).

Animal, Experimental Design, Surgery and Tissue Collection
----------------------------------------------------------

Male Wistar-Kyoto rats (4--5 months old, weight 300--350 g) were obtained from a standard colony. Ketamine anesthesia was used (100 mg/kg body wt) and the balloon catheter (Fogarty 2F) injury of rats left common carotid arteries was performed. tPA (20 nmol/kg, Alteplase, Boehringer Ingelheim Pharma) or 500 μl of vehicle (saline) in Pluronic gel F-127 (BASF) was applied around injured carotids ([@B24]). At days 1, 4, or 14 after injury the perfusion-fixation was done under anesthesia, the absence of endothelium in the injured area was verified by Evans blue dye ([@B9]) and paraffin embedding of common carotids was performed ([@B25]). For microarrays, 1 and 4 days after the operation carotids were rapidly removed and frozen in liquid nitrogen. Total RNA was extracted from left carotid arteries of injured, sham-operated and intact rats (nine animals per group). Microarray analysis was performed ([@B24]).

Morphometry
-----------

Toluidine blue staining of cross-sections (10 μm) with subsequent analysis using a Zeiss microscope coupled to a ProgRess-3008 camera (Kontron Elektronik) and PC with an UTHSCSA ImageTool, version 3.0 (San Antonio, TX, United States) ([@B25]) were performed.

Microarray Analysis
-------------------

Analysis was performed as previously described ([@B16]; [@B24]). Total RNA was isolated with the use of Qiagen RNAeasy Micro kit, the quality of RNA was confirmed. For each probe vessels from three rats were pooled; three hybridizations were done for each treatment group. Microarray analysis was performed at the University of Rochester Microarray Core Facility in accordance to Affymetrix recommendations using Affymetrix rat genome U34A oligonucleotide microarrays with 8799 known genes and expressed sequence tags (ESTs) (Santa Clara, CA, United States). Streptavidin phycoerythrin stain (SAPE, Molecular Probes) was used. Target hybridization was detected and quantified with a Gene Array Scanner (Hewlett Packard/Affymetrix). "Array performance" was assessed. Hybridization efficiency and sensitivity was controlled using control transcripts spiked into the hybridization cocktail. Inter-array variability was assessed by Microarray Analysis Suite 5.0. For data normalization global scaling with target intensity of 500 across all probe sets was used ([@B3]). To lower the rates of overall errors and the estimated false detection the invariant set normalization method and the model-based expression indexes for perfect match (PM)-only arrays using DNA-Chip Analyzer (dChip) software package were applied ([@B19]). The "Present" percentage in all arrays was \>40%. The percentage of "Array-outlier" in all arrays was not more than 5%, showing the absence of serious contamination or hybridization problems. To exclude "Absent" genes filtering was performed limiting the analyses to targets, which were "present" in more than 20% of arrays. A minimal inter-array variability (*SD* ≤ 2%) of the mean signal (with 5% of signals trimmed from both the high and low ends) was observed across the 4458 targets after the presence/absence filtering. Then to identify statistically significant changes in gene expression the significance analysis of microarrays (SAM) software was applied ([@B30]). Comparison with parametric ANOVA and Welch's approximate *t*-test for non-equal variances were also performed (GeneSpring Software). To get very robust results we accepted as significant only genes verified by both analyses ([@B14]).

Software
--------

Microarray Suite 5.0 was used with the default parameters. DNA-Chip Analyzer software was kindly provided by Drs. Cheng Li and Wing Hung Wong, Computational Biology Lab, Department of Biostatistics, Harvard School of Public Health. SAM was kindly provided by the Department of Statistics, Stanford University. GeneSpring 5.0 Software was from Silicon Genetics.

Quantitative Polymerase Chain Reaction (qPCR)
---------------------------------------------

Quantitative RT-PCR analyses were performed using ABI Prism 7900HT sequence detection system (Applied Biosystems). Double-stranded cDNA template preparation and purification were performed with Ambion MessageAmp aRNA kit. The qPCR primers and Master Mix from RT2 Real-Time Gene Expression Assay kits (SuperArray) were used. The effective hybridization was testified by the expression of 7 housekeeping genes including ribosomal proteins L18 (M20156), L18a (X14181) and S9 (X66370), alpha-tubulin (V01227), thymosin beta-4 (M34043), ubiquitin (D17296), beta-actin (V01217), which consistently gave positive signals through all samples analyzed.

Statistical Analysis
--------------------

Results are represented as mean ± SEM. Jandel SigmaStat (*t*-test or ANOVA for multiple comparisons to limit false discovery rate, as appropriate) was used for statistical analysis. *P* \< 0.05 was considered as statistically significant.

Results
=======

tPA and Vessel Remodeling
-------------------------

To assess tPA influence on the injured artery remodeling, we measured the area of lumen, the area, encompassed by the external elastic lamina (EEL), and intima-plus-media area \[termed intima-media thickness (IMT)\]; main parameters reflecting vessel remodeling. Periadventitial application of tPA increased EEL area (*P* \< 0.05; [Figure 1](#F1){ref-type="fig"}) at 1 day, then at 4 days there were significant increases in EEL and lumen areas, and a decrease in IMT (*P* \< 0.05; [Figure 1](#F1){ref-type="fig"}). Fourteen days after tPA treatment, there was still a decrease in IMT, but the other areas were the same (*P* \< 0.05; [Figure 1](#F1){ref-type="fig"}). These effects contrasted markedly with the effects of uPA that induced lumen narrowing, decreases in EEL and increased IMT after injury ([@B23], [@B24]). These data show that the arterial remodeling response stimulated by tPA induces lumen enlargement ([Figure 1](#F1){ref-type="fig"}), increased EEL and decreased IMT, although the decrease in IMT only lasted 14 days.

![Bar graphs summarizing the effects of perivascularly applied recombinant tPA on luminal cross sectional area, external elastic laminae (EEL) area, and Intima-Media Thickness 1, 4, and 14 days after balloon injury to carotid arteries. Control represents balloon injured vessels, which were treated only with Pluronic gel/saline. For lumen, EEL and Intima-Media Thickness areas all injured vessels were compared with their corresponding right uninjured carotid artery in the same animals and the differences were calculated. Results are the means ± S.E.M of 6 to 7 animals in each group. *\*P* \< 0.05 from control. Histological figures depicting the effects of perivascular administration of recombinant tPA on the vessel structure 1, 4, and 14 days after balloon catheter injury of the carotid artery. l -- lumen, i -- intima, m --media, a -- adventitia. Sections are stained with Toluidine Blue; magnification ×63. Scale bar 500 μm.](fphys-10-00493-g001){#F1}

Differential Gene Expression Profiling Induced by tPA
-----------------------------------------------------

To clarify the underlying mechanisms ensuring the vascular remodeling effects of tPA, the *in vivo* microarray analysis of gene expression was carried out. The expression of 8799 genes was investigated 1 and 4 days after the combination of balloon arterial injury plus treatment with recombinant tPA or control (gel plus saline).

One day after the operation in arteries treated with tPA the expressions of 95 transcripts (41 known genes, [Supplementary Table 1A](#SM3){ref-type="supplementary-material"}) were significantly different to those in control samples (*P* ≤ 0.05; confirmed by two statistical tests). Wherein amongst known genes 23 (56.1%) were down-regulated, when 18 (43.9%) were up-regulated after tPA treatment compared to control. At day 4, 53 mRNAs (28 known genes, [Supplementary Table 1B](#SM3){ref-type="supplementary-material"}) were significantly different in tPA group compared to gel-saline group. Among these known genes 5 (17.9%) were down-regulated and 23 (82.1%) were up-regulated compared to control.

In the group of genes differentially expressed after tPA treatment, a few groups of genes participating in the main processes of vascular remodeling including cellular migration, apoptosis and proliferation and inflammation were identified ([Supplementary Tables 1A,B](#SM3){ref-type="supplementary-material"}).

tPA and Differential Expression of Nervous System -- Related Genes
------------------------------------------------------------------

Among genes differentially expressed 1 day after injury and tPA treatment, eight genes were related to nervous system function ([Table 1](#T1){ref-type="table"}). Among these genes, seven were up-regulated, and one was down-regulated. At day four after injury the expression of one gene with the intended relevance to nervous system was increased in arteries treated with tPA. Changes in genes expressions of ≥1.5 fold were observed ([Supplementary Figure 1](#SM1){ref-type="supplementary-material"}). Thus, microarray gene analysis showed that tPA may contribute to the outward vascular remodeling at least partially through local changes in the expression of nervous system genes after arterial injury.

###### 

Transcription profiles of genes related to nervous system and vascular tone regulation differentially expressed in rat carotid arteries treated with tPA compared to control vessels, which only received Pluronic gel/saline, 1 day and 4 days after balloon injury.

  Nervous-system related genes                                          
  -------------------------------------------- ---------- ------ ------ --------------------------------------
  **1 day**                                                             
  Calpain                                      D14478     0.02   up     anti-apoptotic
  Substance P receptor (SPR)                   M64236     0.03   up     pro-inflammatory, vasoactive
  Neural cell adhesion molecule L1             X59149     0.02   up     pro-inflammatory
  NMDA receptor glutamate-binding subunit      S61973     0.03   up     artery dilatation
  Dihydropyrimidinase                          D63704     0.03   up     unknown
  Glycine transporter (GLYT-1)                 U28975     0.03   up     unknown
  Development-related protein Bdm1/NDRG4       AF045564   0.02   up     mitoch
  Ataxin 3                                     Y12319     0.03   down   unknown
  **4 days**                                                            
  Corticotropin releasing factor receptor      U53486     0.01   up     vasodilation
                                                                        
  **Vascular tone regulation related genes**                            
                                                                        
  **1 day**                                                             
  RAC protein kinase alpha                     D30040     0.02   up     anti-apoptotic; dependent on calpain
  Calmodulin (pRCM1)                           X13933     0.02   down   pro-proliferative
  **4 days**                                                            
  Thromboxane A2 receptor                      D32080     0.04   up     pro-inflammatory, pro-apoptotic
  Corticotropin releasing factor receptor      U53486     0.01   up     nerv sys
  Angiotensin II receptor type1                M90065     0.04   up     pro-proliferative
  Non-selective-type endothelin receptor       S65355     0.04   down   pro-proliferative

tPA -- Induced Differential Regulation of Vascular Tone Related Genes
---------------------------------------------------------------------

Genes involved in regulation of vascular tone were discovered to be differentially expressed in arteries both one and 4 days after injury and tPA application ([Table 1](#T1){ref-type="table"}). One day after injury and tPA treatment, one gene was up-regulated and one gene was down-regulated; while at 4 days after injury, three genes were up-regulated and 1 gene was down-regulated. Changes in genes expressions of 1.5--3.0 folds were observed ([Supplementary Figure 2](#SM2){ref-type="supplementary-material"}). These findings suggest the importance of tPA-mediated changes in vascular tone in vascular remodeling.

Discussion
==========

We demonstrated three major results regarding the role of tPA in vascular remodeling after injury. First, exogenous tPA significantly enlarged arterial lumen area at 1 as well as 4 days after balloon injury. Second, we discovered increases in EEL area at both one and 4 days. Finally, tPA decreased IMT at 4 and 14 days. These results show that tPA has a significant effect on vessel structure that appears to be beneficial. Our data are consistent with previous studies where local delivery of tPA via Dispatch catheters, followed by continuous intravenous infusion of tPA for 3 days, prevented intimal hyperplasia after angioplasty ([@B15]). In contrast, an adenoviral construct expressing tPA enhanced neointima formation after angioplasty in a rabbit model ([@B13]). Another study in cholesterol-fed rabbits showed that subcutaneous recombinant tPA inhibited the effect of balloon injury on luminal area compared with controls, but this effect did not reach statistical significance; the potential problem with the delivery method was discussed ([@B1]). Taken together, these results indicate the importance of the model and the method used for tPA administration to evaluate its effects on arterial remodeling.

The gene array data shown here provide information regarding two likely mechanisms of action of tPA in the vessel wall: nerve function and vascular tone. Changes in nervous system--related gene expression after tPA treatment of injured arteries suggest that tPA-induced increases of vascular lumen size can be mediated at least in part through its effects on innervation that is consistent with the previous findings ([@B27]; [@B5]). Some of these genes may affect vasodilatation. For example, NMDA receptor through nitric oxide ([@B7]; [@B11]) or substance P receptor may elicit a neurogenic vasodilatation ([@B8]; [@B4]). Future work will be necessary to define precisely the roles of neurotransmitters in arterial remodeling. Of interest among the other nerve function genes, calpain was found to be highly expressed in the vasculature and is involved in many processes important for vascular remodeling ([@B18]). The involvement of its signaling in vascular remodeling regulation is extensively investigated nowadays ([@B17]). Also smooth muscle cells neurotrophin-3 was shown to be implicated in vessel injury acting in an autocrine manner through its receptor TrkC ([@B6]).

The microarray study also revealed in tPA-treated arteries changes in the expression of four genes related to vascular tone regulation, such as endothelin receptor or angiotensin receptor ([@B29]; [@B26]). One of those genes - corticotrophin releasing factor receptor (U53486) is also involved in nervous system function. Considering that perivascular nerves may also affect vascular tone and induce vasodilatation (as well as tPA itself possesses vasoactive properties) ([@B12]; [@B20]), we may hypothesize that increases in lumen and EEL areas early after injury and tPA application may reflect changes in vascular tone, though it was not pronounced at the later stages due to the nature of vascular tone response.

The most novel finding here is the discovery that changes in genes related to nervous system function as well as vascular tone regulation, were highly significant at early time points, suggesting a possible connection between these two pathways leading to early outward vessel remodeling. There are many examples of relationships between nerves and vessels, especially regarding vascular tone, such as the release of vasoactive intestinal peptide by nerves to promote vasodilation in the gut.

In summary, the present data further support an important role for tPA as a negative regulator of IMT in response to balloon injury, as well as a mediator of favorable arterial remodeling. Furthermore, our genetic analysis reveal a novel role for the interaction between genes involved in the nervous system and those in vascular tone regulation suggesting new approach to limit IMT after injury.
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